Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.
Massa
Elena
E
Department of Medical Oncology, University of Cagliari, Italy.
Dessì
Mariele
M
Gaspardini
Giulio
G
Saba
Federica
F
Cherchi
Valeria
V
Mantovani
Giovanni
G